Department of Medicine, McMaster University, and Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada. smehta@mcmaster.caCONTEXT: Glucose-insulin-potassium (GIK) infusi.....
JAMA. 2005;293:437-446. The CREATE-ECLA Trial Group Investigators Context: Glucose-insulin-potassium (GIK) infusion is a widely applicable, low-cost therapy that has been postulated to improve mortality in pat.....